Broad spectrum of in vivo fitness of human immunodeficiency virus type 1 subpopulations differing at reverse transcriptase codons 41 and 215

Journal of Virology

Volumn 71, Issue 6, 1997, Pages 4479-4484

  Goudsmit, Jaap ^a   De Ronde, Anthony ^a   De Rooij, Esther ^a   De Boer, Rob ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

RNA DIRECTED DNA POLYMERASE; ZIDOVUDINE;

ARTICLE; CODON; GENE MUTATION; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRINAE; PRIORITY JOURNAL; VIRUS GENE; VIRUS REPLICATION; VIRUS TRANSMISSION;

EID: 0030926277     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.6.4479-4484.1997     Document Type: Article

References (36)

1. Angarano, G., L. Monno, A. Appice, A. Gianelli, C. Romanelli, C. Fico, and G. Pastore. 1994. Transmission of zidovudine-resistant HIV-1 through heterosexual contacts. AIDS 8:1013-1014.
2. Boom, R., C. J. Sol, M. M. Salimans, C. L. Jansen, P. M. Wertheim-van Dillen, and J. van der Noordaa. 1990. Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol. 28:495-503.
3. Boucher, C. A., E. O'Sullivan, J. W. Mulder, C. Ramautarsing, P. Kellam, G. Darby, J. M. Lange, J. Goudsmit, and B. A. Larder. 1992. Ordered appearance of zidovudine resistance mutations during treatment of 18 human immunodeficiency virus-positive subjects. J. Infect. Dis. 165:105-110.
4. Boucher, C. A., M. Tersmette, J. M. Lange, P. Kellam, R. E. de Goede, J. W. Mulder, G. Darby, J. Goudsmit, and B. A. Larder. 1990. Zidovudine sensitivity of human immunodeficiency viruses from high-risk, symptom-free individuals during therapy. Lancet 336:585-590.
5. Cao, Y., L. Qin, L. Zhang, J. Safrit, and D. D. Ho. 1995. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N. Engl. J. Med. 332:201-208.
6. Chao, L. 1990. Fitness of RNA virus decreased by Muller's ratchet. Nature 348:454-455.
7. Coffin, J. M. 1995. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 267:483-489.
8. Cornelissen, M., G. Mulder-Kampinga, J. Veenstra, F. Zorgdrager, C. Kuiken, S. Hartman, J. Dekker, L. Van der Hoek, C. Sol, R. Coutinho, and J. Goudsmit. 1995. Syncytium-inducing (SI) phenotype suppression at seroconversion after intramuscular inoculation of a non-syncytium-inducing/SI phenotypically mixed human immunodeficiency virus population. J. Virol. 69:1810-1818.
9. de Jong, M. D., J. Veenstra, N. I. Stilianakis, R. Schuurman, J. M. Lange, R. J. de Boer, and C. A. Boucher. 1996. Host-parasite dynamics and outgrowth of virus containing a single K70R amino acid change in reverse transcriptase are responsible for the loss of human immunodeficiency virus type 1 RNA load suppression by zidovudine. Proc. Natl. Acad. Sci. USA 93:5501-5506.
10. de Ronde, A., E. de Rooij, R. A. Coutinho, and J. Goudsmit. 1996. Zidovudine-resistente HIV-stammen bij intraveneuze-drugsgebruikers en homosexuele mannen in Amsterdam. Ned. Tijdschr. Geneeskd. 140:932-934.
11. de Ronde, A., E. R. de Rooij, F. Zorgdrager, M. Cornelissen, and J. Goudsmit. Unpublished observations.
12. de Wolf, F., J. Goudsmit, D. A. Paul, J. M. A. Lange, C. Hooykaas, P. Schellekens, R. A. Coutinho, and J. van der Noordaa. 1987. Risk of AIDS related complex and AIDS in homosexual men with persistent HIV antigenemia. Br. Med. J. 295:569-572.
13. Duarte, E. A., I. S. Novella, S. Ledesma, D. K. Clarke, A. Moya, S. F. Elena, E. Domingo, and J. J. Holland. 1994. Subclonal components of consensus fitness in an RNA virus clone. J. Virol. 68:4295-4301.
14. Duarte, E. A., I. S. Novella, S. C. Weaver, E. Domingo, S. Wain-Hobson, D. K. Clarke, A. Moya, S. F. Elena, J. C. de la Torre, and J. J. Holland. 1994. RNA virus quasispecies: significance for viral disease and epidemiology. Infect. Agents Dis. 3:201-214.
15. Erice, A., D. L. Mayers, D. G. Strike, K. J. Sannerud, F. E. McCutchan, K. Henry, and H. H. J. Balfour. 1993. Primary infection with zidovudine-resistant human immunodeficiency virus type 1. N. Engl. J. Med. 328:1163-1165.
16. Goudsmit, J., A. de Ronde, D. D. Ho, and A. S. Perelson. 1996. Human immunodeficiency virus fitness in vivo: calculations based on a single zidovudine resistance mutation at codon 215 of reverse transcriptase. J. Virol. 70:5662-5664.
17. Hogervorst, E., S. Jurriaans, F. de Wolf, A. van Wijk, A. Wiersma, M. Valk, M. Roos, B. Van Gemen, R. Coutinho, F. Miedema, et al. 1995. Predictors for non-and slow progression in human immunodeficiency virus (HIV) type 1 infection: low viral RNA copy numbers in serum and maintenance of high HIV-1 p24-specific but not V3-specific antibody levels. J. Infect. Dis. 171: 811-821.
18. Holland, J. J., J. C. de la Torre, D. K. Clarke, and E. Duarte. 1991. Quantitation of relative fitness and great adaptability of clonal populations of RNA viruses. J. Virol. 65:2960-2967.
19. Kellam, P., C. A. Boucher, and B. A. Larder. 1992. Fifth mutation in human immunodeficiency virus type 1 reverse transcriptase contributes to the development of high-level resistance to zidovudine. Proc. Natl. Acad. Sci. USA 89:1934-1938.
20. Keulen, W., C. Boucher, and B. Berkhout. 1996. Nucleotide substitution patterns can predict the requirements tor drug-resistance of HIV-1 proteins. Antiviral Res. 31:45-57.
21. Kumar, S., K. Tamura, and M. Nei. 1993. Molecular evolutionary genetics analysis (MEGA), version 1.01. Institute of Molecular Evolutionary Genetics, The Pennsylvania State University, University Park.
22. Larder, B. A., G. Darby, and D. D. Richman. 1989. HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Science 243:1731-1734.
23. Mellors, J. W., L. A. Kingsley, C. R. Rinaldo, Jr., J. A. Todd, B. S. Hoo, R. P. Kokka, and P. Gupta. 1995. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann. Intern. Med. 122:573-579.
24. Mellors, J. W., C. R. Rinaldo, Jr., P. Gupta, R. M. White, J. A. Todd, and L. A. Kingsley. 1996. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272:1167-1170.
25. Mohri, H., M. K. Singh, W. T. Ching, and D. D. Ho. 1993. Quantitation of zidovudine-resistant human immunodeficiency virus type 1 in the blood of treated and untreated patients. Proc. Natl. Acad. Sci. USA 90:25-29.
26. Mulder-Kampinga, G. A., A. Simonen, C. L. Kuiken, J. Dekker, H. J. Scherpbier, P. van de Perre, K. Boer, and J. Goudsmit. 1495. Similarity in env and gag genes between genomic RNAs of human immunodeficiency virus type 1 (HIV-1) from mother and infant is unrelated to time of HIV-1 RNA positivity in the child. J. Virol. 69:2285-2296.
27. Nagylaki, T. 1992. Introduction to theoretical population dynamics. Springer-Verlag, KG, Berlin, Germany.
28. Najera, I., A. Holguin, M. E. Quinones-Mateu, M. A. Munoz-Fernandez, R. Najera, C. Lopez-Galindez, and E. Domingo. 1995. pol gene quasispecies of human immunodeficiency virus: mutations associated with drug resistance in virus from patients undergoing no drug therapy. J. Virol. 69:23-31.
29. Nijhuis, M., C. A. B. Boucher, and R. Schuurman. 1995. Sensitive procedure for the amplification of HIV-1 RNA using a combined reverse-transcription and amplification reaction. BioTechniques 19:178-180.
30. Novella, I. S., D. K. Clarke, J. Quer, E. A. Duarte, C. H. Lee, S. C. Weaver, S. F. Elena, A. Moya, E. Domingo, and J. J. Holland. 1995. Extreme fitness differences in mammalian and insect hosts after continuous replication of vesicular stomatitis virus in sandfly cells. J. Virol. 69:6805-6809.
31. Novella, I. S., S. F. Elena, A. Moya, E. Domingo, and J. J. Holland. 1995. Size of genetic bottlenecks leading to virus fitness loss is determined by mean initial population fitness. J. Virol. 69:2869-2872.
32. Perelson, A., A. U. Neumann, M. Markowitz, J. M. Leonard, and D. D. Ho. 1996. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271:1582-1586.
33. van den Hoek, J. A. R., R. A. Coutinho, H. J. A. van Haastrecht, A. W. van Zadelhoff, and J. Goudsmit. 1988. Prevalence and risk factors of HIV infections among drug users and drug-using prostitutes in Amsterdam. AIDS 2:55-60.
34. Van Gemen, B., T. Kievits, R. Schukkink, D. Van Strijp, L. T. Malek, R. Sooknanan, H. G. Huisman, and P. Lens. 1993. Quantification of HIV-1 RNA in plasma using NASBA during HIV-1 primary infection. J. Virol. Methods 43:177-187.
35. Wahlberg, J., J. Fiore, G. Angarano, M. Uhlen, and J. Albert. 1994. Apparent selection against transmission of zidovudine resistant human immunodeficiency virus type 1 variants. J. Infect. Dis. 169:611-614.
36. Yerly, S., A. Rakik, S. Kinloch, B. Hirschel, and L. Perrin. 1996. Persistence of ZDV resistant mutations in patients with primary HIV infection, p. 82. In Abstracts of the Fifth International Workshop on HIV Drug Resistance.